134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study.
CNS spectrums（2020）
摘要
This study was funded by Teva Pharmaceuticals, Petach Tikva, Israel.
更多查看译文
关键词
Targeted Therapy,Medication Adherence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要